Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1989 Jan;209(1):88–98. doi: 10.1097/00000658-198901000-00013

The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence.

B Ringe 1, C Wittekind 1, W O Bechstein 1, H Bunzendahl 1, R Pichlmayr 1
PMCID: PMC1493890  PMID: 2535924

Abstract

The role of hepatic transplantation in patients with nonresectable liver or bile duct cancer remains a controversial issue. An analysis of 95 consecutive cases was undertaken to evaluate retrospectively the pathological tumor stage--in accordance with the TNM system--and outcome after transplantation. Included were patients with the following diagnoses: hepatocellular carcinoma (n = 52), cholangiocellular carcinoma (n = 10), hepatoblastoma (n = 2), hemangiosarcoma (n = 2), bile duct carcinoma (n = 20), and liver metastases from different primary tumors (n = 9). The overall actuarial survival rate at 5 years was 20.4%. Median survival improved significantly within the last 4 years as compared to the preceding era (18.06 vs. 4.0 months). Currently 27 patients are alive, with the longest follow-up more than 12 years. The incidences of residual or recurrent tumor were 27 and 28, respectively. Particularly in patients who underwent transplantation for hepatocellular or bile duct carcinoma without extra-hepatic tumor spread, the results were significantly better; median survival time achieved for these two groups were 120 (p less than 0.01) and 35 months (p less than 0.05). Prolonged survival without tumor recurrence was not seen in patients with cholangiocellular carcinoma or liver metastases. These results demonstrate clearly that liver transplantation for hepatobiliary malignancy is still justified on the premises of careful patient selection by adequate tumor staging.

Full text

PDF

Images in this article

89Fig. 1.
on p.89

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adson M. A., Van Heerden J. A. Major hepatic resections for metastatic colorectal cancer. Ann Surg. 1980 May;191(5):576–583. doi: 10.1097/00000658-198005000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beazley R. M., Hadjis N., Benjamin I. S., Blumgart L. H. Clinicopathological aspects of high bile duct cancer. Experience with resection and bypass surgical treatments. Ann Surg. 1984 Jun;199(6):623–636. doi: 10.1097/00000658-198406000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bismuth H., Castaing D., Ericzon B. G., Otte J. B., Rolles K., Ringe B., Sloof M. Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry. Lancet. 1987 Sep 19;2(8560):674–676. doi: 10.1016/s0140-6736(87)92453-6. [DOI] [PubMed] [Google Scholar]
  4. Bismuth H., Castaing D., Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg. 1988 Feb;12(1):39–47. doi: 10.1007/BF01658484. [DOI] [PubMed] [Google Scholar]
  5. Bismuth H., Houssin D., Ornowski J., Meriggi F. Liver resections in cirrhotic patients: a Western experience. World J Surg. 1986 Apr;10(2):311–317. doi: 10.1007/BF01658152. [DOI] [PubMed] [Google Scholar]
  6. Calne R. Y., Williams R. Liver transplantation in man. I. Observations on technique and organization in five cases. Br Med J. 1968 Nov 30;4(5630):535–540. doi: 10.1136/bmj.4.5630.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Calne R. Y., Williams R., Rolles K. Liver transplantation in the adult. World J Surg. 1986 Jun;10(3):422–431. doi: 10.1007/BF01655302. [DOI] [PubMed] [Google Scholar]
  8. Fortner J. G., MacLean B. J., Kim D. K., Howland W. S., Turnbull A. D., Goldiner P., Carlon G., Beattie E. J., Jr The seventies evolution in liver surgery for cancer. Cancer. 1981 May 1;47(9):2162–2166. doi: 10.1002/1097-0142(19810501)47:9<2162::aid-cncr2820470909>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  9. Ishak K. G., Sesterhenn I. A., Goodman Z. D., Rabin L., Stromeyer F. W. Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases. Hum Pathol. 1984 Sep;15(9):839–852. doi: 10.1016/s0046-8177(84)80145-8. [DOI] [PubMed] [Google Scholar]
  10. Iwatsuki S., Gordon R. D., Shaw B. W., Jr, Starzl T. E. Role of liver transplantation in cancer therapy. Ann Surg. 1985 Oct;202(4):401–407. doi: 10.1097/00000658-198510000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Iwatsuki S., Klintmalm G. B., Starzl T. E. Total hepatectomy and liver replacement (orthotopic liver transplantation) for primary hepatic malignancy. World J Surg. 1982 Jan;6(1):81–85. doi: 10.1007/BF01656377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Iwatsuki S., Shaw B. W., Jr, Starzl T. E. Experience with 150 liver resections. Ann Surg. 1983 Mar;197(3):247–253. doi: 10.1097/00000658-198303000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Iwatsuki S., Starzl T. E., Todo S., Gordon R. D., Esquivel C. O., Tzakis A. G., Makowka L., Marsh J. W., Koneru B., Stieber A. Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc. 1988 Feb;20(1 Suppl 1):498–504. [PMC free article] [PubMed] [Google Scholar]
  14. Krom R. A., Gips C. H., Houthoff H. J., Newton D., van der Waaij D., Beelen J., Haagsma E. B., Slooff M. J. Orthotopic liver transplantation in Groningen, The Netherlands (1979-1983). Hepatology. 1984 Jan-Feb;4(1 Suppl):61S–65S. doi: 10.1002/hep.1840040717. [DOI] [PubMed] [Google Scholar]
  15. Margreiter R., Niederwieser D., Frommhold H., Schönitzer D., Gratwohl A., Huber C. Tumor recurrence after liver transplantation followed by high-dose cyclophosphamide, total body irradiation, and autologous bone marrow transplantation for treatment of metastatic liver disease. Transplant Proc. 1987 Feb;19(1 Pt 3):2403–2404. [PubMed] [Google Scholar]
  16. McIntire K. R., Vogel C. L., Primack A., Waldmann T. A., Kyalwazi S. K. Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinoma. Cancer. 1976 Feb;37(2):677–683. doi: 10.1002/1097-0142(197602)37:2<677::aid-cncr2820370211>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  17. Mühlbacher F., Piza F. Orthotopic liver transplantation for secondary malignancies of the liver. Transplant Proc. 1987 Feb;19(1 Pt 3):2396–2398. [PubMed] [Google Scholar]
  18. O'Grady J. G., Polson R. J., Rolles K., Calne R. Y., Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg. 1988 Apr;207(4):373–379. doi: 10.1097/00000658-198804000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Okamoto E., Tanaka N., Yamanaka N., Toyosaka A. Results of surgical treatments of primary hepatocellular carcinoma: some aspects to improve long-term survival. World J Surg. 1984 Jun;8(3):360–366. doi: 10.1007/BF01655077. [DOI] [PubMed] [Google Scholar]
  20. Pichlmayr R. Is there a place for liver grafting for malignancy? Transplant Proc. 1988 Feb;20(1 Suppl 1):478–482. [PubMed] [Google Scholar]
  21. Pichlmayr R., Ringe B., Bechstein W. O., Lauchart W., Neuhaus P. Approach to primary liver cancer. Recent Results Cancer Res. 1988;110:65–73. doi: 10.1007/978-3-642-83293-2_9. [DOI] [PubMed] [Google Scholar]
  22. Pichlmayr R., Ringe B., Lauchart W., Bechstein W. O., Gubernatis G., Wagner E. Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer. World J Surg. 1988 Feb;12(1):68–77. doi: 10.1007/BF01658489. [DOI] [PubMed] [Google Scholar]
  23. Pichlmayr R., Ringe B., Lauchart W., Wonigeit K. Liver transplantation. Transplant Proc. 1987 Feb;19(1 Pt 1):103–112. [PubMed] [Google Scholar]
  24. Shimamura Y., Gunvèn P., Takenaka Y., Shimizu H., Shima Y., Akimoto H., Arima K., Takahashi A., Kitaya T., Matsuyama T. Combined peripheral and central chemoembolization of liver tumors. Experience with lipiodol-doxorubicin and gelatin sponge (L-TAE). Cancer. 1988 Jan 15;61(2):238–242. doi: 10.1002/1097-0142(19880115)61:2<238::aid-cncr2820610206>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  25. Sitzmann J. V., Order S. E., Klein J. L., Leichner P. K., Fishman E. K., Smith G. W. Conversion by new treatment modalities of nonresectable to resectable hepatocellular cancer. J Clin Oncol. 1987 Oct;5(10):1566–1573. doi: 10.1200/JCO.1987.5.10.1566. [DOI] [PubMed] [Google Scholar]
  26. Starzl T. E., Groth C. G., Brettschneider L., Moon J. B., Fulginiti V. A., Cotton E. K., Porter K. A. Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery. 1968 Apr;63(4):549–563. [PMC free article] [PubMed] [Google Scholar]
  27. Starzl T. E., Iwatsuki S., Shaw B. W., Jr, Nalesnik M. A., Farhi D. C., Van Thiel D. H. Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet. 1986 Feb;162(2):145–148. [PMC free article] [PubMed] [Google Scholar]
  28. Starzl T. E., Iwatsuki S., Van Thiel D. H., Gartner J. C., Zitelli B. J., Malatack J. J., Schade R. R., Shaw B. W., Jr, Hakala T. R., Rosenthal J. T. Evolution of liver transplantation. Hepatology. 1982 Sep-Oct;2(5):614–636. doi: 10.1002/hep.1840020516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Starzl T. E., Koep L. J. Surgical approaches for primary and metastatic liver neoplasms, including total hepatectomy with orthotopic liver transplantation. Prog Clin Cancer. 1978;7:181–193. [PubMed] [Google Scholar]
  30. Søreide O., Czerniak A., Blumgart L. H. Large hepatocellular cancers: hepatic resection or liver transplantation? Br Med J (Clin Res Ed) 1985 Sep 28;291(6499):853–857. doi: 10.1136/bmj.291.6499.853. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES